Long term observations in a patient with pseudohypoaldosteronism

R J Hogg1, J F Marks, D Marver

  • 1Department of Pediatrics, Baylor University Medical Center, Dallas, TX 75246.

Insights

Severe pseudohypoaldosteronism (PHA) requires strict dietary management, including low potassium and high sodium intake, to achieve normal growth. This case highlights successful long-term management of a pediatric patient with persistent PHA.

Area of Science:

  • Pediatric Endocrinology
  • Nephrology
  • Metabolic Disorders

Background:

  • Pseudohypoaldosteronism (PHA) is a rare condition characterized by aldosterone resistance.
  • Severe PHA in infants presents with significant electrolyte imbalances, including hyponatremia and hyperkalemia.

Observation:

  • A patient with severe PHA, diagnosed at 10 days old, experienced life-threatening complications including cardiopulmonary arrest after a gastrointestinal illness.
  • Despite persistent severe PHA, the patient achieved normal growth (95th percentile for height and weight) by age 12.5 years.
  • Management involved a specialized low-potassium formula and substantial salt supplementation.

Findings:

  • Serial studies revealed normal aldosterone binding, suppressible renin and aldosterone levels, and normal proximal tubule function.
  • Increased prostaglandin excretion was noted, but inhibition with indomethacin provided no benefit.
  • Impaired distal tubule function was evident during water diuresis.

Implications:

  • Strict dietary manipulation, specifically low potassium and high sodium intake, is crucial for managing severe PHA and achieving normal growth.
  • This case underscores the possibility of successful long-term management and normal development in pediatric patients with persistent PHA.
  • Further research into the specific mechanisms of PHA and potential therapeutic targets, such as prostaglandin pathways, is warranted.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...